RESEARCH STUDIES & CLINICAL TRIALS
With over 600 published studies, we can let the science speak for itself
We encourage a broad range of scientific research. Over $60 million has been invested in independent studies exploring the advanced benefits of MitoQ.
Leading institutions around the world have studied MitoQ’s cellular health optimization in over 600 peer-reviewed scientific papers and 14 clinical trials to date.
Our product development team continues to explore the leading edge of cellular health science, resulting in over 60 global patents for our molecular technology.
Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults
MitoQ decreases free radical production by mitochondria, and significantly supports arterial function in older adults and therefore the health of the arteries. In the clinical trial it was validated that: MitoQ greatly improved the ability of arteries to dilate (by 42%), MitoQ significantly supports the health of aorta & MitoQ significantly fights oxidative Stress.Read the summary
Mitochondria-Targeted Antioxidant Supplementation Improves 8km Time Trial Performance in Middle-Aged Trained Male Cyclist
The study showed that after 4 weeks of MitoQ supplementation, the mean completion time for a time trial was 1.3% faster and an increase of 10 watts of power. MitoQ supplementation may be an effective nutritional strategy to attenuate exercise-induced increases in oxidative damage to lipids and improve cycling performance.Read the summary
The influence of acute high dose MitoQ on urinary kidney injury markers in healthy adults
Results found that acute, high-dose MitoQ supplementation did not result in high concentrations of kidney injury biomarkers compared to placebo samples. Preliminary evidence is that ongoing MitoQ use in the normal range (10mg-20mg) is beneficial to kidney health.Read the summary